Mgat1 is down-regulated by IL7RA∗C; IL2RA∗T is opposed by Mgat1 and vitamin D3, but IL2RA∗T optimizes branching and mitigates the risk of MS when combined with enhanced N-glycosylation of CTLA-4. Here, MGAT1 is linked to myeloid sarcoma.